価格表

在庫・価格 : 2024年04月20日 21時17分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
PD-1, Human, DuoSet Kit <Programmed Death-1, DuoSet Kit>
データシート※最新のデータシートでない場合があります
DY1086 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥141,000
(未発注)
追加

在庫・価格 : 2024年04月20日 21時17分 現在

PD-1, Human, DuoSet Kit <Programmed Death-1, DuoSet Kit>

  • 商品コード:DY1086
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥141,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Cheng HY et al. Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma. PLoS ONE 2014;9(11):e95870
Cheng HY et al
2014/01/01
Sample Type: Plasma PubMed
2 Bartee MY et al. Tumor-Localized Secretion of Soluble PD1 Enhances Oncolytic Virotherapy. Cancer Res. 2017 Jun;77(11):2952-2963
Bartee MY et al
2017/01/01
Sample Type: Cell Culture Supernates,Serum PubMed
3 Guo Y et al. Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression. PLoS ONE 2018;13(2):e0192704
Guo Y et al
2018/01/01
Species: Human PubMed
4 Kruger S et al. Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer. Oncoimmunology 2017;6(5):e1310358
Kruger S et al
2017/01/01
Species: Human PubMed
5 Di Pace AL et al. Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor In Exosome-Mediated Cytotoxicity Against Tumor. Cancers (Basel) 2020 03;12(3)
Di Pace AL et al
2020/01/01
Species: Human PubMed
6 Larrinaga G et al. Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma. Cancers (Basel) 2021 Feb;13(4)
Larrinaga G et al
2021/01/01
Species: Human PubMed
  • No.: 1
  • 文献情報:
    Cheng HY et al. Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma. PLoS ONE 2014;9(11):e95870
    Cheng HY et al
    2014/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Bartee MY et al. Tumor-Localized Secretion of Soluble PD1 Enhances Oncolytic Virotherapy. Cancer Res. 2017 Jun;77(11):2952-2963
    Bartee MY et al
    2017/01/01
  • 備考:
    Sample Type: Cell Culture Supernates,Serum
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Guo Y et al. Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression. PLoS ONE 2018;13(2):e0192704
    Guo Y et al
    2018/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kruger S et al. Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer. Oncoimmunology 2017;6(5):e1310358
    Kruger S et al
    2017/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Di Pace AL et al. Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor In Exosome-Mediated Cytotoxicity Against Tumor. Cancers (Basel) 2020 03;12(3)
    Di Pace AL et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Larrinaga G et al. Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma. Cancers (Basel) 2021 Feb;13(4)
    Larrinaga G et al
    2021/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed